Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial

Abstract Objective To assess whether the antiseizure medication levetiracetam may improve cognition in individuals with Alzheimer's disease who have not previously experienced a seizure. Methods We performed a randomized, double‐blind, placebo‐controlled crossover pilot study in individuals with mil...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Arjune Sen, Sofia Toniolo, Xin You Tai, Mary Akinola, Mkael Symmonds, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Gabriel Davis Jones, Younes Tabi, Raquel Maio, Eleni Frangou, Sharon Love, Sian Thompson, Rohan Van Der Putt, Sanjay G. Manohar, Rupert McShane, Masud Husain
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-12-01
Serie:	Epilepsia Open
Soggetti:	antiseizure medications dementia epilepsy Oxford Memory Test seizure
Accesso online:	https://doi.org/10.1002/epi4.13070
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!